Understanding how metabolites affect COPD symptoms and treatment
Leveraging Serum Metabolomics to Understand Clinical Phenotypes in COPD
This study is looking at how tiny molecules in your body, called metabolites, can help us understand the different symptoms and experiences of people with COPD, so we can create more personalized treatments just for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10874755 on NIH RePORTER |
What this research studies
This research investigates the role of metabolites, which are small molecules found in the body, in understanding the diverse symptoms and outcomes of chronic obstructive pulmonary disease (COPD). By analyzing blood samples from patients, the study aims to identify specific metabolite profiles that correlate with different clinical manifestations of COPD. This could lead to more personalized treatment strategies based on individual metabolic profiles, ultimately improving patient care and outcomes. The research will be conducted over five years, with a focus on training the principal investigator in both clinical and translational research methodologies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic obstructive pulmonary disease (COPD) who are willing to provide blood samples for metabolomic analysis.
Not a fit: Patients without a diagnosis of COPD or those who are not able to provide blood samples may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with COPD.
How similar studies have performed: Other research has shown promising results in using metabolomics to understand various diseases, suggesting that this approach could be beneficial for COPD as well.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Labaki, Wassim W — University of Michigan at Ann Arbor
- Study coordinator: Labaki, Wassim W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.